Interleukin 2 receptor antagonists for kidney transplant recipients

BACKGROUND: Interleukin 2 receptor antagonists (IL2Ra) are used as induction therapy for prophylaxis against acute rejection in kidney transplant recipients. Use of IL2Ra has increased steadily since their introduction, but the proportion of new transplant recipients receiving IL2Ra differs around t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cochrane Database Syst Rev
Asıl Yazarlar: Webster, Angela C, Ruster, Lorenn P, McGee, Richard G, Matheson, Sandra L, Higgins, Gail Y, Willis, Narelle S, Chapman, Jeremy R, Craig, Jonathan C
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Ltd 2010
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7154335/
https://ncbi.nlm.nih.gov/pubmed/20091551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003897.pub3
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller